AVITA Medical, Inc.

RCEL Nasdaq CIK: 0001762303

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 28159 AVENUE STANFORD, VALENCIA, CA, 91355
Mailing Address 28159 AVENUE STANFORD, VALENCIA, CA, 91355
Phone 661-568-1317
Fiscal Year End 1231
EIN 202578762

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events February 12, 2026 View on SEC
10-K Annual financial report February 12, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment January 30, 2026 View on SEC
8-K Current report of material events January 13, 2026 View on SEC
8-K Current report of material events January 5, 2026 View on SEC
8-K Current report of material events November 6, 2025 View on SEC
10-Q Quarterly financial report November 6, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment October 17, 2025 View on SEC
8-K Current report of material events October 17, 2025 View on SEC
4 Insider stock transaction report August 29, 2025 View on SEC

Annual Reports

10-K February 12, 2026
  • AVITA Medical's Recell System is a groundbreaking device for severe burns, chronic wounds, and other skin conditions.
  • Significant progress on Permeaderm, including a strategic partnership with Stedical Scientific Inc. in January 2024.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.